Cargando…

Anaphylaxis to additives in vaccines

Anaphylaxis in connection with the administration of vaccines occurs only very rarely. Triggers of immunoglobulin IgE-mediated and non-IgE-mediated anaphylaxis—in addition to the active ingredient itself—may be excipients contained in the vaccine due to their special properties. Some of the excipien...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahler, Vera, Junker, Ann-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194891/
https://www.ncbi.nlm.nih.gov/pubmed/35729887
http://dx.doi.org/10.1007/s40629-022-00215-8
_version_ 1784726840801230848
author Mahler, Vera
Junker, Ann-Christine
author_facet Mahler, Vera
Junker, Ann-Christine
author_sort Mahler, Vera
collection PubMed
description Anaphylaxis in connection with the administration of vaccines occurs only very rarely. Triggers of immunoglobulin IgE-mediated and non-IgE-mediated anaphylaxis—in addition to the active ingredient itself—may be excipients contained in the vaccine due to their special properties. Some of the excipients in medicinal products are the same compounds used as additives in food. Furthermore, residues from the manufacturing process (e.g., chicken egg white, casein, antibiotics, formaldehyde) or contaminants (e.g., from the primary packaging material) may be potential triggers of anaphylaxis in vaccines. This review article provides an overview of ingredients in vaccines that pose an allergenic risk potential. The components of COVID-19 vaccines approved and marketed in Germany are discussed with regard to their potential for triggering anaphylaxis and possible pathophysiological mechanisms involved.
format Online
Article
Text
id pubmed-9194891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-91948912022-06-17 Anaphylaxis to additives in vaccines Mahler, Vera Junker, Ann-Christine Allergo J Int Review Anaphylaxis in connection with the administration of vaccines occurs only very rarely. Triggers of immunoglobulin IgE-mediated and non-IgE-mediated anaphylaxis—in addition to the active ingredient itself—may be excipients contained in the vaccine due to their special properties. Some of the excipients in medicinal products are the same compounds used as additives in food. Furthermore, residues from the manufacturing process (e.g., chicken egg white, casein, antibiotics, formaldehyde) or contaminants (e.g., from the primary packaging material) may be potential triggers of anaphylaxis in vaccines. This review article provides an overview of ingredients in vaccines that pose an allergenic risk potential. The components of COVID-19 vaccines approved and marketed in Germany are discussed with regard to their potential for triggering anaphylaxis and possible pathophysiological mechanisms involved. Springer Medizin 2022-06-14 2022 /pmc/articles/PMC9194891/ /pubmed/35729887 http://dx.doi.org/10.1007/s40629-022-00215-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Mahler, Vera
Junker, Ann-Christine
Anaphylaxis to additives in vaccines
title Anaphylaxis to additives in vaccines
title_full Anaphylaxis to additives in vaccines
title_fullStr Anaphylaxis to additives in vaccines
title_full_unstemmed Anaphylaxis to additives in vaccines
title_short Anaphylaxis to additives in vaccines
title_sort anaphylaxis to additives in vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194891/
https://www.ncbi.nlm.nih.gov/pubmed/35729887
http://dx.doi.org/10.1007/s40629-022-00215-8
work_keys_str_mv AT mahlervera anaphylaxistoadditivesinvaccines
AT junkerannchristine anaphylaxistoadditivesinvaccines